ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases

Applications open until 10 September 2026

The European Rare Diseases Research Alliance (ERDERA) has launched its Clinical Trial Call 2026, supporting multinational early-phase clinical trials that aim to accelerate the development of new therapies for people living with rare diseases.

The call is open to international research consortia and seeks to foster collaboration across Europe to address unmet medical needs and advance innovative treatment options.

For full details on the scope of the call, eligibility criteria and application process, please visit the official ERDERA webpage.

---